'Low risk' antibiotic has led to an almost untreatable superbug, study finds
byThe Peter Doherty Institute for Infection and ImmunityVRE bacteria on a petri dish and Rifaximin antibiotics. Credit: Adrianna TurnerA new study has found that an antibiotic for liver disease
Updated on: November 07,2024
'Low risk' antibiotic has led to an almost untreatable superbug, study finds
byThe Peter Doherty Institute for Infection and ImmunityVRE bacteria on a petri dish and Rifaximin antibiotics. Credit: Adrianna TurnerA new study has found that an antibiotic for liver disease
Updated on:November 07,2024
